MedTrace Logo

A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers

NCT04016025 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-05-10

No results posted yet for this study

Summary

Untersuchung der Adhärenz zur topischen Standardtherapie bei Patienten mit chronischem Handekzem in Abhängigkeit von der Galenik

Conditions

  • Adherence, Patient
  • Chronic Eczema

Interventions

BEHAVIORAL

Adherence to topical standard therapy assessed

Adherence defined as percentage of patients applying at least aimed daily dose

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Jena University Hospital

    lead OTHER

Principal Investigators

  • Peter Elsner, Prof. Dr. med. · University hospital Jena

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-02
Primary Completion
2022-03-11
Completion
2022-04-14

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04016025 on ClinicalTrials.gov